Clinical trial
Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor…
NCT00160173 · ASCEND Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00160173 |
|---|---|
| Title | Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy |
| Official title | Efficacy Study Comparing 0.9 g and 1.25 g EstroGel® 0.03% Doses With Placebo in the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated With Menopause |
| Lead sponsor | ASCEND Therapeutics, Industry |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Postmenopausal Symptoms |
| Intervention type | Drug, Other |
| Interventions | Estrogel, Placebo |
| Enrollment | 221 |
| Start date | Dec 2, 2004 |
| Primary completion | Sep 6, 2005 |
| Completion | Sep 6, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 13, 2022 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: